Clinical Trial Update: Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether low-dose acetylsalicylic acid can reduce diarrhea induced by anti-cancer targeted therapies has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Cancer | Phase 2 | Status: WITHDRAWN